Safety of probiotics

Scandinavian Journal of Nutrition/Naringsforskning

Volumn 48, Issue 1, 2004, Pages 42-48

  Gueimonde, Miguel ^a   Ouwehand, Arthur C ^a   Salminen, Seppo ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bifidobacteria; Infections; Lactic acid bacteria; Probiotics; Safety; Side effects

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL VIRULENCE; BIFIDOBACTERIUM; CONFERENCE PAPER; DIET SUPPLEMENTATION; FOOD INTAKE; GENETICALLY MODIFIED FOOD; HOST PARASITE INTERACTION; HUMAN; INFECTION; LACTOBACILLUS; MEDICAL INFORMATION; MEDICAL LITERATURE; NONHUMAN; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PUBLICATION; RISK ASSESSMENT; SAFETY;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; LACTOBACILLUS;

EID: 1842503147     PISSN: 11026480     EISSN: None     Source Type: Journal    
DOI: 10.1080/11026480410026447     Document Type: Conference Paper

References (25)

1. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002; 50(Suppl. III): iii54-9.
2. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35: 1155-60.
3. Mogensen G, Salminen S, O'Brien J, Ouwehand AC, Holzapfel W, Shortt C, et al. Food microorganisms - health benefits, safety evaluation and strains with documented history of use in foods. Bull IDF 2002; 377: 4-9.
4. Saarela M, Lähteenmäki L, Crittenden R, Salminen S, Mattila-Sandholm T. Gut bacteria and health foods - the European perspective. Int J Food Microbiol 2002; 78: 99-117.
5. Salminen SJ, von Wright AJ, Ouwehand AC, Holzapfel WH. Safety assessment of probiotics and starters. In: Adams MR, Nout MJR, eds. Fermentation and food safety, 1st edn. Gaithersburg, MD: Aspen; 2001. p. 239-51.
6. Temmerman R, Scheirlinck I, Huys G, Swings J. Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis. Appl Environ Microbiol 2003; 69: 220-6.
7. Yeung PSM, Sanders ME, Kitts CL, Cano R, Tong PS. Species-specific identification of commercial probiotic strains. J Dairy Sci 2002; 85: 1039-51.
8. Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003; 82: 59-70.
9. Lherm T, Monet C, Nougière B, Soulier M, Larbi D, le Gall C, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002; 28: 797-801.
10. Kayser FH. Safety aspects of enterococci from the medical point of view. Int J Food Microbiol 2003; 88: 255-62.
11. Franz CM, Stiles ME, Schleifer KH, Holzapfel WH. Enterococci in foods - a conundrum for food safety. Int J Food Microbiol 2003; 88: 105-22.
12. Apostolou E, Kirjavainen PV, Saxelin M, Rautelin H, Valtonen V, Salminen SJ, et al. Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol 2001; 31: 35-9.
13. Cocconcelli PS, Cattivelli D, Gazzola S. Gene transfer of vancomycin and tetracyclin resistances among Enterococcus faecalis during cheese and sausage fermentations. Int J Food Microbiol 2003; 88: 315-23.
14. Peters J, Mac K, Wichermann-Schauer H, Klein G, Ellerbroek L. Species distribution and antibiotic resistance patterns of enterococci isolated from food of animal origin in Germany. Int J Food Microbiol 2003; 88: 311-4.
15. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-9.
16. Rayes N, Hansen S, Seehofer D, Müller AR, Serke S, Bengmark S, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002; 18: 609-15.
17. Costalos C, Skouteri V, Gounaris A, Sevatiadou S, Triandafilidou A, Ekonomidou C, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96.
18. Bernet MF, Brassart D, Neeser J-R, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-9.
19. Lyczak. Commensal bacteria increase invasion of intestinal epithelium by Salmonella enterica serovar Typhi. Infect Immun 2003; 71: 6610-4.
20. Marteau P, Minekus M, Havenaar R, Huis in't Veld JHJ. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and effects of bile. J Dairy Sci 1997; 80: 1031-7.
21. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999; 45: 223-8.
22. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JMT Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999; 5: 290-2.
23. Mercenier A, Wiederman U, Breitender H. Edible genetically modified microorganisms and plants for improved health. Curr Opin Biotechnol 2001; 12: 510-5.
24. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1352-5.
25. Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003; 21: 785-9.